Santa Cruz community raises $97,000 for adaptive van for boy with Duchenne Muscular Dystrophy ...

Parents of children with Duchenne muscular dystrophy say they have appealed to the Prosecutor’s Office, accusing police of ...

Jon Anning, a Slippery Rock University professor, has done extensive research on effects and treatment for Duchenne muscular ...

Santhera Pharmaceuticals (SIX: SANN) announces that the Board of Directors of the Italian Medicines Agency, AIFA, has approved the reimbursement of AGAMREE® (vamorolone) for the treatment of patients ...

SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular ...

Pratteln, Switzerland, April 28, 2026 -- Santhera Pharmaceuticals (SIX: SANN) announces that the Board of Directors of the Italian Medicines Agency, AIFA, has approved the reimbursement of AGAMREE (R) ...

Santhera Pharmaceuticals (SIX:SANN, OTC:SPHDF, FRA:S3F0), the Swiss rare disease specialist, has received a positive opinion ...

The EMA has backed broader pediatric use of Agamree and Crysvita, lowering age thresholds for rare genetic diseases affecting muscle and bone development.

Data underscore the differentiated capability of the clinically validated FORCE platform to cross the blood-brain barrier -WALTHAM, Mass., ...

Heart failure and arrhythmia deaths now exceed heart attacks and keep rising. Stronger policies and early screening are key ...

Georgia’s Ministry of Health is continuing work to expand state-funded medical services for patients with rare neuromuscular ...

Pratteln, Switzerland, April 28, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces its full year results for the year ended 31 December 2025. Analyst says Japan's support for Taiwan upends ...